Home › NCT06087224
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
Recruiting
Who can join
0 Days · All sexes
Full eligibility criteria
Inclusion Criteria: GROUP 1: Community hospital clinicians To be eligible to participate in this study, an individual must meet all of the following criteria: 1. A clinician who attends newborn resuscitations at a participating community hospital spoke site. 2. Provision of informed oral consent prior to any mandatory study specific procedures and analyses. GROUP 2: At-risk outborn neonates To be eligible for this study, a neonate born in a participating community hospital spoke site must meet \*at least one\* of the following inclusion criteria 1. Preterm birth at less than 32 weeks' gestation at delivery; OR 2. Need for advanced resuscitation defined as: 1. positive pressure ventilation (PPV) initiated soon after birth and continued for at least 10 minutes; OR 2. placement of an alternative airway (endotracheal tube or laryngeal mask) to provide PPV; OR 3. chest compressions. Exclusion Criteria: GROUP 1: Community hospital clinicians None GROUP 2: At-risk outborn neonates A neonate born in a participating community hospital spoke site who meets any of the following criteria will be excluded from the study: 1. Birth outside of the hospital birthing center. 2. Neonatal transport team present at time of birth and providing resuscitative care. 3. Severe congenital anomaly necessitating intensive care or surgery in the first two weeks of life. 4. Plan for comfort care (non-resuscitation) following delivery. 5. In-person neonatology-trained physician present for the resuscitation.
About the study
The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.
What is being tested
- Teleneonatology (other)
Sponsor: Mayo Clinic · Participants: 947 · Started: Mar 5, 2024
Contact the study team
- Jennifer Fang, MD, MS · Phone: 5072669397
- Bart M Demaerschalk, MD, MSc · Phone: 4803018000
Official record on ClinicalTrials.gov — NCT06087224
Locations in the U.S.
| Alaska | Providence Alaska Medical Center, Anchorage Bartlett Regional Hospital, Juneau PeaceHealth Ketchikan Medical Center, Ketchikan |
| Oklahoma | Chickasaw Nation Medical Center, Ada Jackson County Memorial Hospital, Altus Great Plains Regional Medical Center, Elk City University of Oklahoma Health Sciences Center, Oklahoma City |
| Washington | Island Health, Anacortes Providence Regional Medical Center Everett, Everett Olympic Medical Center, Port Angeles Seattle Children's Hospital, Seattle University of Washington, Seattle Central Washington Health Services Association d/b/a Confluence Health, Wenatchee |
| Wisconsin | Prairie Ridge Health, Columbus Fort HealthCare, Fort Atkinson University of Wisconsin-Madison, Madison Sauk Prairie Healthcare, Prairie du Sac Reedsburg Area Medical Center, Reedsburg Watertown Regional Medical Center, Watertown |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.